MedTrace Logo

Adverse Events Report of Inactivated COVID-19 Vaccine

NCT05026879 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4040

Last updated 2021-09-02

No results posted yet for this study

Summary

Numerous vaccination studies are conducted to protect against COVID-19 infection, and preclinical and clinical studies are still ongoing worldwide. During this extraordinary period, the necessity to perform COVID-19 vaccine studies and immunization programs together has emerged. Many manufacturing companies have started mass production of vaccines accepting the risk of failure of vaccines during trials. Vaccine Adverse Effects (VAEs) need to be documented quickly. We aimed to determine the VAEs and to compare the frequency of VAEs between groups according to socio-demographic characteristics after the inactivated vaccine (Corona Vac®) was administered to healthcare workers (HCWs) in Turkey.

In this study, an online questionnaire was delivered to volunteer healthcare workers across the whole country. Sociodemographic characteristics, medical history, history of COVID-19 infection, and VAEs occurring after the first and second doses of inactivated vaccine were evaluated.

Conditions

Interventions

BIOLOGICAL

Inactivated COVID-19 vaccine (CoronaVac)

The adverse events due to an inactivated COVID-19 vaccine.

Sponsors & Collaborators

  • Bozyaka Training and Research Hospital

    lead OTHER

Principal Investigators

  • Selma Tosun, Prof. · Izmir Bozyaka Education and Research Hospital

  • Hulya Ozkan Ozdemir, MD · Izmir Bozyaka Education and Research Hospital

  • Esin Erdogan, Assoc. Prof. · University of Health Sciences, Izmir Bozyaka Education and Research Hospital

  • Seniz Akcay, Assoc. Prof. · University of Health Sciences, Izmir Bozyaka Education and Research Hospital

  • Murat Aysin, Assis. Prof. · Izmir Katip Celebi University, Faculty of Medicine

  • Neslihan Eskut, MD · University of Health Sciences, Izmir Bozyaka Education and Research Hospital

  • Pinar Ortan, Prof. · University of Health Sciences, Izmir Bozyaka Education and Research Hospital

  • Burak Eskut, MD · University of Izmir Katip Celebi, Ataturk Education and Research Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-14
Primary Completion
2021-02-28
Completion
2021-03-14

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05026879 on ClinicalTrials.gov